The COMBINE project is part of the IMI AMR Accelerator. One of the scientific aims of COMBINE is to improve and standardize the pneumonia animal model used in AMR research and to develop improved tools to reliably translate results in animals into results in humans. This workshop addressed the need for standard protocols to ease […]
This webinar provided a unique opportunity for the antibiotic community. The Innovative Medicines Initiative's GNA NOW Consortium was looking for a novel antibiotic compound to progress to a clinical candidate and informed participants about what was in it for interested candidates, and how to submit a proposal, among others. View the agenda and register now. […]
This webinar will cover the use of knowledge management tools in the IMI AMR Accelerator and how these can be used to both enhance data analysis workflows and also promote collaborations across projects and teams. To support these efforts the AMR Data Management group have developed a set of database and visualisation tools based […]
GNA NOW Open Call webinar II This webinar provided a unique opportunity for the antibiotic community. The Innovative Medicines Initiative’s GNA NOW Consortium was looking for a novel antibiotic compound to progress to a clinical candidate and informed participants about what was in it for interested candidates, and how to submit a proposal, among others.
About twenty people attended this webinar which focused on TB research within the IMI AMR Accelerator. During the first part of this TB research focused webinar, Martin Boeree (UNITE4TB and Radboud UMC) introduced UNITE4TB, the newest member of the AMR Accelerator. The second part, given by Michel Pieren (BioVersys) and Alfonso Mendoza-Losana (ERA4TB and University […]
The 2nd Annual meeting for the Cross-IMI AMR Accelerator community was held online on 28 September 2021 and brought together >160 members of the 8 AMR Accelerator projects. After an introduction by COMBINE, a round of project updates was organised with an official introduction of the newest project, UNITE4TB. Martin Boeree, UNITE4TB Project Coordinator, presented […]
Recap of the first UNITE4TB webinar: Panel discussion on global burden of TB On 03 March 2022, UNITE4TB held its first in a series of webinars being organized by project partners, Instituto de Saúde Pública da Universidade do Porto (ISPUP) and the European Respiratory Society (ERS). The session featured a presentation by Prof. Mario Raviglione […]
About fifteen people attended this webinar which provided the most recent updates of ongoing TB research within the IMI AMR Accelerator. The following speakers addressed the challenges of their respective TB projects: Michael Hoelscher (Medical University München) who gave an update and intro to UNITE4TB; Santiago Ferrer-Bazaga (Universidad Carlos III Madrid) who discussed some challenges […]
The 3rd AMR Accelerator Cross-project Meeting for the AMR Accelerator community, a total of 9 projects, took place on 06 April 2022 in Basel, Switzerland. Please find more details here and the final agenda below: DOWNLOAD THE FULL PROGRAMME HERE DOWNLOAD THE PRESENTATIONS HERE
In June 2022, the Paul-Ehrlich-Institut organised a two-day virtual expert workshop on behalf of the COMBINE project. The workshop aimed to address the challenges in developing monoclonal antibodies (mAbs) against antimicrobial resistance (AMR) pathogens, with a specific focus on ESCAPE pathogens (E. faecium, S. aureus, C. difficile, A. baumannii, P. aeruginosa, and Enterobacteriaceae). The workshop […]